Ownership history in Weaver Consulting Group · 7 quarters on record
This page tracks every 13F SEC filing in which Weaver Consulting Group reported a position in FORTRESS BIOTECH INC (FBIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 19,532 | -1,080 | -5.2% | 0.02% | $71K | $3.66 |
| 2025 Q3 | REDUCED | 20,612 | -24,305 | -54.1% | 0.02% | $76K | $3.70 |
| 2025 Q2 | REDUCED | 44,917 | -1,500 | -3.2% | 0.02% | $84K | $1.86 |
| 2025 Q1 | ADDED | 46,417 | +23,419 | +101.8% | 0.02% | $72K | $1.56 |
| 2024 Q4 | ADDED | 22,998 | +5,700 | +33.0% | 0.01% | $47K | $2.03 |
| 2024 Q3 | ADDED | 17,298 | +5,895 | +51.7% | 0.01% | $25K | $1.45 |
| 2024 Q2 | INITIATED | 11,403 | — | — | 0.01% | $19K | — |
As of 2025 Q4 — sorted by position size